The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
BackgroundImmunotherapy has become the first-line treatment for metastatic mismatch repair deficient (dMMR) colorectal cancer. The efficacy and safety of neoadjuvant immunotherapy for the treatment of non-metastatic dMMR colorectal cancer remain unclea…